Literature DB >> 2824833

Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.

J E Shaw1, R G Petit, K Leung.   

Abstract

Epstein-Barr virus (EBV)-transformed tamarin (Saguinus oedipus) cells (B95-8) were selected for growth in medium with reduced serum and then transferred to serum-free medium which consisted of RPMI 1640 supplemented with insulin, transferrin, and selenium. Serum-free cells in continuous passage for 1 year had a morphology, growth rate, and culture density which approached those of B95-8 cells grown with serum. The cells expressed virus-induced antigens, including the EBV-associated DNA polymerase. Cells exposed to EBV-inducing agents, n-butyric acid and phorbol 12-myristate-13-acetate, produced transforming virus with titers comparable to those of cultures grown with serum. These findings demonstrate that serum is neither required for the growth of B95-8 cells nor necessary for induction or full expression of the EBV lytic phase in these cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824833      PMCID: PMC256028          DOI: 10.1128/JVI.61.12.4033-4037.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

Authors:  P Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

3.  Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus-negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine (thymidine kinase-virus antigen-immunofluorescence-herpesvirus fingerprints).

Authors:  B Hampar; J G Derge; L M Martos; J L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

4.  Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.

Authors:  K Sugawara; F Mizuno; T Osato
Journal:  Nat New Biol       Date:  1972-10-25

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  DNA-dependent DNA polymerases from HeLa cell nuclei. II. Template and substrate utilization.

Authors:  A Schlabach; B Fridlender; A Bolden; A Weissbach
Journal:  Biochem Biophys Res Commun       Date:  1971-08-20       Impact factor: 3.575

7.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

8.  Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.

Authors:  P Gerper; J Whang-Peng; J H Monroe
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

9.  Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells.

Authors:  W Henle; G Henle
Journal:  J Virol       Date:  1968-03       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  4 in total

1.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

2.  Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.

Authors:  J E Shaw; L A Baglia; K Leung
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes.

Authors:  Hao Wang; Chi Ma; Yanlai Lu; Xu Ji; Yongsheng Pang; Fang Hua; Lianxian Cui; Denian Ba; Wei He
Journal:  Cell Mol Immunol       Date:  2013-08-05       Impact factor: 11.530

4.  An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells.

Authors:  Cheng-Chung Lee; Chih-Ya Yang; Li-Ling Lin; Tzu-Ping Ko; Alarng Hsun-Lang Chang; Stanley Shi-Chung Chang; Andrew H-J Wang
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.